Boundless Bio (BOLD) shares surge over 95% premarket after the company and and Serapha Bio entered into a definitive all-stock merger agreement. Following the transaction, the combined company will ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Before going public, the ...
The last time a single injection changed the trajectory of medicine, it was insulin, and that was over a century ago. On June 9, 2026, a human being received a shot that scientists are calling ...
The Food and Drug Administration has agreed to reverse its rejection of Regenxbio’s experimental gene therapy for a rare and fatal brain disease, the company said, the latest about-face by the agency ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results